HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Om P S Patel Selected Research

O-methylmurrayamine A

9/2017Anti-colon cancer activity of Murraya koenigii leaves is due to constituent murrayazoline and O-methylmurrayamine A induced mTOR/AKT downregulation and mitochondrial apoptosis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Om P S Patel Research Topics

Disease

2Neoplasms (Cancer)
04/2019 - 09/2017
1Malaria
01/2021
1Type 2 Diabetes Mellitus (MODY)
01/2021
1Body Weight (Weight, Body)
04/2019
1Breast Neoplasms (Breast Cancer)
04/2019
1Colonic Neoplasms (Colon Cancer)
09/2017
1Visceral Leishmaniasis (Kala Azar)
01/2017
1Insulin Resistance
01/2016

Drug/Important Bio-Agent (IBA)

1NaphthoquinonesIBA
01/2021
1Proguanil (Paludrine)FDA Link
01/2021
1Chloroquine (Aralen)FDA LinkGeneric
01/2021
1Atovaquone (Mepron)FDA Link
01/2021
1proguanil drug combination atovaquone (malarone)FDA Link
01/2021
1Advanced Glycation End ProductsIBA
01/2021
1TubulinIBA
04/2019
1carbazoleIBA
04/2019
1AntioxidantsIBA
09/2017
1murrayazolineIBA
09/2017
1Reactive Oxygen Species (Oxygen Radicals)IBA
09/2017
1AlkaloidsIBA
09/2017
1O-methylmurrayamine AIBA
09/2017
1PyridinesIBA
01/2017
1Leptin ReceptorsIBA
01/2016
1Blood Glucose (Blood Sugar)IBA
01/2016
1Hypoglycemic Agents (Hypoglycemics)IBA
01/2016
1koenidineIBA
01/2016

Therapy/Procedure

1Oral Administration
04/2019
1Therapeutics
09/2017